IMI, Innovative Medicines Initiative launches new Calls for proposals
Convocatoria 18ª (abierta)
Call Identifier: H2020-JTI-IMI2-2019-18-two-stage
Type of actions: Research and Innovation Action (RIA)
Total Indicative Budget: 160,737,760 € (IMI +EFPIA contributions)
Stage 1 Submission deadline: 26 September 2019, 17h. Stage 2 Submission deadline: 26 March 2020, 17h.
Topics:
1. Central repository of digital pathology slides to support the development of artificial intelligence tools
2. Health Outcomes Observatories – empower patients with tools to measure their outcomes in a standardised manner creating transparency of health outcomes
3. Improving patient access, understanding and adherence to healthcare information: an integrated digital health information project
4. Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials
5. Accelerating research & development for advanced therapy medicinal products
6 Supporting the development of chimeric antigen receptor T cells
Más información en bit.ly/IMI2Call18 
y documento adjunto. IMI organiza webinarios para cada topic según el calendario en www.imi.europa.eu/news-events/events/imi2-call-18-19-webinars que podrán verse también a posteriori.
Convocatoria 19ª (restringida)
Call Identifier: H2020-JTI-IMI2-2019-19-single-stage
Type of actions: Research and Innovation Action (RIA)
Indicative Budget: From the IMI2 JU: 20 M€ (public funding)
Submission deadline: 26 September 2019, 17h.
Content: Es una convocatoria restringida a proyectos 2014-2015 para maximizar su impacto. Los proyectos IMI a los que está dirigida está convocatoria 19 son: ADAPT-SMART, BEAt-DKD, DO-IT, HARMONY, INNODIA, ITCC-P4, MOPEAD, NGN-PET, PRISM, RADAR-CNS, RESCEU, RHAPSODY, TransQST.
Más información en: http://bit.ly/IMI2Call19 y documento adjunto. 
